Insider Transactions in Q1 2023 at Sellas Life Sciences Group, Inc. (SLS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2023
|
Robert Francomano Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+50.0%
|
-
|
|
Feb 02
2023
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
58,000
+20.89%
|
-
|
|
Feb 02
2023
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+28.84%
|
-
|
|
Feb 02
2023
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+20.76%
|
-
|
|
Feb 02
2023
|
Katherine Bach Kalin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
|
Feb 02
2023
|
David A Scheinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+35.3%
|
-
|
|
Feb 02
2023
|
Robert L Van Nostrand Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+36.23%
|
-
|
|
Feb 02
2023
|
Jane Wasman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+36.23%
|
-
|
|
Feb 02
2023
|
John Varian Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+36.23%
|
-
|